Cash & Equivalents
Procter & Gamble Cash & Equivalents decreased by 3.1% to $10.83B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.8%, from $10.23B to $10.83B. Over 4 years (FY 2021 to FY 2025), Cash & Equivalents shows relatively stable performance with a -1.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase signals improved liquidity and financial flexibility, while a decrease may indicate heavy capital expenditure, debt repayment, or aggressive share buybacks.
Detailed definition
Represents the most liquid assets on the balance sheet, including physical currency and short-term investments with matu...
Peer comparison
Large-cap technology peers often maintain high cash balances to fund rapid innovation and offset the cyclical nature of consumer electronics.
cash_and_equivalentsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.29B | $10.37B | $11.54B | $8.53B | $7.21B | $6.71B | $6.85B | $7.60B | $8.25B | $9.73B | $7.89B | $6.83B | $9.48B | $12.16B | $10.23B | $9.12B | $9.56B | $11.17B | $10.83B |
| QoQ Change | — | +0.8% | +11.3% | -26.1% | -15.4% | -7.0% | +2.1% | +10.8% | +8.6% | +18.0% | -18.9% | -13.5% | +38.9% | +28.2% | -15.8% | -10.9% | +4.8% | +16.9% | -3.1% |
| YoY Change | — | — | — | — | -29.9% | -35.3% | -40.6% | -10.9% | +14.3% | +45.1% | +15.1% | -10.1% | +15.0% | +24.9% | +29.7% | +33.5% | +0.8% | -8.1% | +5.8% |
Cash & Equivalents at Other Companies
Frequently Asked Questions
- What is Procter & Gamble's cash & equivalents?
- Procter & Gamble (PG) reported cash & equivalents of $10.83B in Q4 2025.
- How has Procter & Gamble's cash & equivalents changed year-over-year?
- Procter & Gamble's cash & equivalents increased by 5.8% year-over-year, from $10.23B to $10.83B.
- What is the long-term trend for Procter & Gamble's cash & equivalents?
- Over 4 years (2021 to 2025), Procter & Gamble's cash & equivalents has grown at a -1.8% compound annual growth rate (CAGR), from $10.29B to $9.56B.
- What does cash & equivalents mean?
- Money in the bank and very short-term investments that can be turned into cash almost instantly.